New Key Statistics Module, Z-Score and F-Score
OTCPK:CSCIF Key Ratios
| Market Cap $ M | 5.73 |
| Enterprise Value $ M | 2.41 |
| P/E(ttm) | 1.16 |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.38 |
| Price/Sales | 0.70 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 0.82 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 8.00 |
| EPS (TTM) $ | 4.76 |
| Beneish M-Score | 1.35 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.57 |
| EV-to-EBITDA | -0.82 |
| PEG | -- |
| Shares Outstanding M | 1.00 |
| Net Margin (%) | 77.89 |
| Operating Margin % | -56.40 |
| Pre-tax Margin (%) | -52.64 |
| Quick Ratio | 3.90 |
| Current Ratio | 4.33 |
| ROA % (ttm) | 28.25 |
| ROE % (ttm) | 83.52 |
| ROIC % (ttm) | -34.34 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.22 |
CSCIF Number of Guru Trades
CSCIF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CSCIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CSCIF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cosciens Biopharma Inc Insider Transactions
No Available Data
News about OTCPK:CSCIF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers